Tumgik
#Shock Wave Therapy Device Market Trends
Tendinitis Treatment Market Share: Analyzing Size and Growth Trends
Market Overview –
During the projected period of 2023–2032, the market for tendinitis treatments is expected to grow at a 3.7% CAGR to reach USD 263.95 billion by 2032.
The tendinitis treatment market is growing steadily, driven by the increasing demand for effective tendinitis therapy options. As more individuals experience tendon inflammation and related injuries, there's a heightened focus on innovative therapies to alleviate pain and promote healing. The market for tendinitis therapy continues to evolve, offering patients various treatment modalities for improved outcomes.
The tendinitis treatment market focuses on providing solutions for a common musculoskeletal condition characterized by inflammation or irritation of a tendon. Tendinitis can affect various parts of the body, including the shoulders, elbows, wrists, knees, and heels, leading to pain, stiffness, and limited movement. This market encompasses a range of treatment options, including medications, physical therapy, braces, and in severe cases, surgery.
One of the primary drivers of the tendinitis treatment market is the increasing incidence of tendinitis-related injuries, attributed to factors such as overuse, repetitive motion, poor ergonomics, aging, and sports activities. As the population ages and lifestyles become more sedentary, the prevalence of tendinitis is expected to rise, driving demand for effective treatment modalities.
Moreover, advancements in medical technology and treatment approaches have expanded the options available for managing tendinitis. Innovative therapies such as extracorporeal shockwave therapy (ESWT), platelet-rich plasma (PRP) injections, and regenerative medicine techniques offer promising alternatives to traditional treatments, providing patients with more options for pain relief and faster recovery.
The COVID-19 pandemic has impacted the tendinitis treatment market, with disruptions in healthcare services, delayed diagnoses, and changes in patient behavior. However, the pandemic has also highlighted the importance of self-care and home-based treatments, leading to increased interest in home exercises, ergonomic modifications, and telemedicine consultations for managing tendinitis symptoms.
Despite challenges such as limited reimbursement for certain treatments and variability in treatment outcomes, the tendinitis treatment market is expected to grow as awareness about the condition increases and as research efforts continue to improve treatment efficacy and patient outcomes. With ongoing innovation and collaboration among healthcare providers, researchers, and industry stakeholders, the tendinitis treatment market holds promise for addressing the needs of patients with tendinitis in the future.
Segmentation –
The Americas & Europe Tendinitis Treatment market is segmented on the basis of type, treatment, and end user.
On the basis of type, the market is segmented into Achilles tendinitis, supraspinatus tendinitis, tennis or golfer's elbow, De Quervain's tenosynovitis, and others.
On the basis of treatment, the market is segmented into diagnosis, therapy, shock wave therapy or surgery, medical devices, devices, and others.
Diagnosis is further segmented into physical examination, imaging tests, ultrasound, Magnetic Resonance Imaging (MRI) Scans, and others.
Therapy is further segmented into non-pharmacological and pharmacological therapy. Non-pharmacological therapy includes rest therapy, heat & cold therapy, occupational therapy, physical therapy, and others. Pharmacological therapy includes OTC drugs or pain relievers, corticosteroids injections, platelet-rich plasma (PRP), and others.
Medical devices is further segmented mechanical band, support tape, pre-cut strips, continuous rolls, and others.
On the basis of end user, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Regional Analysis –
The tendinitis treatment market's regional analysis reveals varying prevalence rates, treatment approaches, and healthcare infrastructures worldwide. North America leads with a high incidence of tendinitis cases and a strong focus on sports medicine and rehabilitation therapies. Europe follows suit, with an emphasis on conservative treatments and physical therapy modalities. In the Asia-Pacific region, increasing sports participation and aging populations contribute to market growth, driving demand for tendinitis treatments. Latin America and Africa show potential for market expansion with improving healthcare access and rising awareness of musculoskeletal conditions. Market players must adapt their treatment options to meet regional preferences and regulatory requirements, considering factors like affordability, accessibility, and cultural influences.
Key Players –
Some of the Tendinitis Treatment Companies are Almatica Pharma, Inc. based in the US, AstraZeneca from the US, Bayer headquartered in Germany, Boehringer Ingelheim Pharmaceuticals, Inc. situated in the US, Merck & Co., Inc. operating out of the US, Pfizer also located in the US, alongside other contributors.
Related Reports –
Steam Autoclave
Diagnostic Imaging
Neonatal Thermoregulation
Immunotherapy Drugs
For more information visit at MarketResearchFuture
0 notes
pranay-234 · 8 months
Text
Plantar Fasciitis Treatment Market Top Winning Strategies by 2019-2028
Plantar fasciitis, a common and often debilitating condition, affects millions of individuals globally. It is characterized by intense heel pain, making each step an uncomfortable ordeal. For those afflicted, finding relief is a top priority. The Plantar Fasciitis Treatment Market plays a pivotal role in alleviating the suffering of those with this condition. In this article, we embark on a journey through the landscape of plantar fasciitis treatment, exploring the latest advancements, trends, and the path to a soothing walk to recovery.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐎𝐟  𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-toc-and-sample/10817
𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬
The global response to the COVID-19 pandemic remains a top priority for pharmaceutical and biotech companies, as well as governments worldwide. Their collaborative efforts are focused on supporting the development of vaccines, ensuring adequate supplies of critical medicines, and addressing the multifaceted challenges presented by the pandemic. Currently, there is a robust pipeline with approximately 115 vaccine candidates and 155 therapeutic molecules in research and development, reflecting the extraordinary global effort to combat the virus.
The increased demand for commonly used drugs, such as Hydroxychloroquine, for managing COVID-19 has opened significant opportunities for manufacturers in the COVID-19 management drugs sector. This heightened demand is particularly crucial, as many developed countries have faced shortages of these essential medications.
This unprecedented demand for COVID-19 vaccines and treatments is expected to drive substantial growth within the pharmaceutical and biotechnology industry. The industry is primed for significant expansion in the coming years, underlining the critical role it plays in global health security.
Understanding Plantar Fasciitis
Plantar fasciitis is a condition in which the plantar fascia, a thick band of tissue that runs across the bottom of the foot, becomes inflamed. This inflammation can lead to severe heel pain, especially during the first few steps in the morning or after periods of rest.
𝐏𝐫𝐞-𝐛𝐨𝐨𝐤 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/plantar-fasciitis-treatment-market/purchase-options
Plantar Fasciitis Treatment Market
The Plantar Fasciitis Treatment Market is dedicated to providing solutions for those suffering from this condition. It encompasses a range of treatments, including both conservative approaches and medical interventions.
Advancements in Conservative Treatments
Physical Therapy: Physical therapy has become a cornerstone of plantar fasciitis treatment. Therapists employ exercises and techniques to stretch and strengthen the affected area, offering relief and preventing future issues.
Orthotic Devices: Custom orthotic insoles and supportive footwear have evolved to provide superior comfort and support to those with plantar fasciitis, reducing strain on the plantar fascia.
Night Splints: Night splints are designed to maintain the foot in a dorsiflexed position, ensuring that the plantar fascia remains elongated during sleep. This helps alleviate morning pain.
Medical Interventions
Corticosteroid Injections: In cases of severe pain and inflammation, corticosteroid injections may provide short-term relief by reducing inflammation around the plantar fascia.
Shockwave Therapy: Extracorporeal Shock Wave Therapy (ESWT) is an innovative approach that uses acoustic waves to stimulate healing and reduce pain in the affected area.
Emerging Trends
In the Plantar Fasciitis Treatment Market, emerging trends are focusing on minimally invasive surgical interventions for chronic cases that do not respond to conservative treatments. These procedures can offer long-lasting relief for patients.
𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/10817
The Path to Soothing Recovery
For individuals with plantar fasciitis, relief is not just about walking pain-free; it's about reclaiming their quality of life. The Plantar Fasciitis Treatment Market is committed to providing a soothing walk to recovery through innovative solutions that ease pain and improve mobility.
As the market continues to evolve, there's an unwavering dedication to advancing treatment options, improving patient outcomes, and offering hope to those who have endured the discomfort of plantar fasciitis. The journey to a soothing walk to recovery is an inspiring one, illustrating the remarkable progress that is possible in the field of healthcare.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
0 notes
modi02 · 1 year
Text
0 notes
jean-perry · 1 year
Text
0 notes
dbmrmarketnews · 2 years
Text
Electrotherapy Market: Size, Trends, Opportunities, Demand, Growth Analysis and Forecast By 2028
Recent study report released by Data Bridge Market research with titled “Electrotherapy Market” (covering USA, Europe, China, Japan, India, South East Asia and etc.) that highlighting opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. Electrotherapy market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyse major upstream raw materials, major equipment, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.
Data Bridge Market Research analyses the market to grow at a CAGR of 3.95% in the above-mentioned forecast period. Rise in the competitiveness and new product launches drives the electrotherapy market.
Download Exclusive Sample Report PDF (with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-electrotherapy-market
Market Overview:
Electrotherapy is defined as a therapy which uses electric energy in the medical treatment. Electrotherapy has numerous uses which include pain management, cardiology, tissue repair, urine and fecal incontinence. Most athletic trainers and therapists use electrotherapy system in the management of athletic injuries. Transcutaneous spinal electro analgesia, pulsed short wave diathermy, spinal cord stimulation, micro- current therapy, percutaneous electrical nerve stimulation among others are some of the common electrotherapy treatments.
Rise in the competitiveness and new product launches is the vital factor escalating the market growth, also rise in the cases of spinal injuries among population, rise in the prevalence of chronic conditions, increase in the geriatric population and rise in the regulatory approvals from key players are the major factors among others driving the electrotherapy market. Moreover, rise in the technological advancements and modernization in the healthcare devices and rise in the demand from the emerging economies will further create new opportunities for electrotherapy market
To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-electrotherapy-market
Electrotherapy Market Scope and Market Size
The electrotherapy market is segmented on the basis of technology, application, therapy and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of technology, the electrotherapy market is segmented into transcutaneous electrical nerve stimulation (TENS), neuromuscular electrical stimulation (NMES), inferential current (IFC), percutaneous electrical nerve stimulation (PENS), electronic muscle stimulator (EMS), spinal cord stimulation (SCS), electro-acupuncture (EA) and others.
Based on application, the electrotherapy market is segmented into chronic wound healing, neuromuscular dysfunction, pain management, tissue repair, musculoskeletal disorder, physical therapy, iontophoresis and others.
Based on therapy, the electrotherapy market is segmented into extracorporeal shock wave therapy, magnetic field therapy, ultrasound therapy, micro current therapy, interferential current therapy and others.
The electrotherapy market is also segmented on the basis of end-user into hospitals, rehabilitation centres and clinics.
What benefits does DBMR study is going to provide?
Latest industry influencing trends and development scenario
Open up New Markets
To Seize powerful market opportunities
Key decision in planning and to further expand market share
Identify Key Business Segments, Market proposition & Gap Analysis
Assisting in allocating marketing investments
Highlights of TOC:
Chapter 1: Market overview
Chapter 2: Global Electrotherapy Market
Chapter 3: Regional analysis of the Global Electrotherapy Market industry
Chapter 4: Electrotherapy Market segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Explore Detailed Table of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-electrotherapy-market
Geographically, the following regions together with the listed national/local markets are fully investigated:
– APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
– Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
– North America (U.S., Canada, and Mexico)
– South America (Brazil, Chile, Argentina, Rest of South America)
– MEA (Saudi Arabia, UAE, South Africa)
Critical Insights Related to the Electrotherapy Included in the Report:
Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
Value chain analysis of prominent players in the market
Current trends influencing the dynamics of this market across various geographies
Recent mergers, acquisitions, collaborations, and partnerships
Revenue growth of this industry over the forecast period
Marketing strategy study and growth trends
Growth driven factor analysis
Emerging recess segments and region-wise market
An empirical evaluation of the curve of this market
Ancient, Present, and Probable scope of the market from both prospect value and volume
Browse Trending Reports:
Dental Syringes Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-dental-syringes-market
Moles Treatment Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-moles-treatment-market
Vascular Grafts and Peripheral Stents Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-vascular-grafts-and-peripheral-stents-market
Over the Counter (OTC) Drugs Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-over-the-counter-otc-drugs-market
Mouth Ulcers Treatment Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-mouth-ulcers-treatment-market
Pertussis Treatment Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-pertussis-treatment-market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
0 notes
Text
Electrotherapy Market : 2021 Industry Analysis By Global Size, Share, Growth, Statistics, Trends, Key Players Analysis With Regional Forecast To 2027
Electrotherapy Market Overview :
The electrotherapy market is expected to register a CAGR of 5.10% during the forecast period 2020-2027, to reach USD 1,463.74 million by 2027. MRFR recognizes the following companies as the key players in the global electrotherapy market —Medtronic plc (Ireland), Alimed, Inc (US), Cogentix Medical, Inc. (US), St. Jude Medical Inc.(US), Zynex Medical (US), DJO Global, Inc.(US), Livanova Plc (UK), Neuromextrix Inc.(US), Nervo Corp (US), and Boston Scientific Corporation (US)
Electrotherapy Market Highlights :
The global electrotherapy market is expected to have a market value of 1,463.74 million by 2027. Electrotherapy is a pain-relieving treatment that uses electric impulses to relax muscles, improve blood circulation, repair tissues, and promote bone formation. The use of physiotherapy in the treatment of a variety of diseases has increased demand for electrotherapy around the world. The key players in the electrotherapy market are focusing on various growth strategies such as product launches andsigning contracts and agreements for expanded reach and optimized operational costs.
For instance, in May 2018, DJO Global (US) entered a strategic partnership with XPO Logistics (US), a global logistics provider of cutting-edge supply chain solutions, to manage portions of DJO Global’s North American distribution activities.Similarly, in January 2018, LivaNova, PLC (UK) acquired ImThera Medical, Inc. (US), a privately held company developing an implantable neurostimulation device system.The global electrotherapy market is highly competitive, with players competing and partnering to gain a substantial market share.
Electrotherapy Market Segment Analysis :
The global electrotherapy market is segmented based on treatment type, device type, application, and end user. The global electrotherapy market based on treatment type has been segmented into extracorporeal shock wave therapy, Interferential Current Therapy (IC), magnetic field therapy, ultrasound therapy, Transcutaneous Electrical Nerve Stimulation (TENS) therapy, micro-current therapy, Transcutaneous Spinal Electro Analgesia (TSE), Pulsed Short Wave Diathermy (PSWD), Spinal Cord Stimulation (SCS), Percutaneous Electrical Nerve Stimulation (PENS), and others.The market, by device type, has been segmented into Transcutaneous Electrical Neural Stimulator (TENS), Electronic Muscle Stimulator (EMS), Interferential Stimulator (IF), High Voltage Pulsed Galvanic Stimulator (HVPGS), Microcurrent Stimulator (MC) or Microcurrent Electrical Neuromuscular Stimulator (MENS), and others.
The global electrotherapy market, by application, has been segmented into pain management, neuromuscular dysfunction, urine and fecal incontinence, acute and chronic edema, tissue repair, iontophoresis, orthopedics, cardiology, and others. The pain management segment is further divided into chronic pain, chronic fatigue, migraine headaches, wound healing, diabetic nerve pain, stimulating bone growth, and others.The global electrotherapy market, by end user, is bifurcated into hospitals & clinics, rehabilitation centers, long-term care centers, and others.
Get Sample Copy @ : https://www.marketresearchfuture.com/sample_request/3185
Electrotherapy Market Regional Analysis :
The global electrotherapy market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing healthcare expenditure,growing research funding,and the rising clinical trials and R&Din electrotherapy.
Europe held a significant share in the globalelectrotherapy market. This can be attributed to the prevalence of diabetes among all age groups in the region, mostly due to overweight and obese population, unhealthy diet, and physical inactivity. In addition, an increase in the cancer survivability rate in the region is also anticipated to drive the growth of the electrotherapy market. Moreover, high healthcare spending and increasing R&D pushed the market growth.
Asia-Pacific is expected to witness the highest market growth potential over the forecast period due to the rising prevalence of neuropathy and other associated disorders, increasing adoption of electrotherapy systems, government initiatives to provide palliative care in the APAC countries, and support to improve public health. The electrotherapy market in the Middle East & Africa is showing steady growth due to the growing geriatric population andincreasing prevalence of painful diabetic neuropathy.
Electrotherapy Market Key Findings of the Study :
The global electrotherapy market is estimated to reach USD 1,463.74million by 2027 at a CAGR of 5.10% during the assessment period of 2020 to 2027.
The Americas accounted for the largest share of the global electrotherapy market due to the presence of prominent players in the US, established healthcare infrastructure, and product clearances from regulatory authorities.
Based ontreatment type, the Transcutaneous Electrical Nerve Stimulation (TENS) therapy segment accounted for the largest market share of 16.10% in 2019.
Based on device type, the Transcutaneous Electrical Neural Stimulator (TENS) is expected to be the fastest-growing segment at a CAGR of 5.81% during the forecast period.
Based on application, the pain management segment accounted for the largest market share of 21.68% in 2019.
On the basis of end user, the hospitals & clinics segment was the fastest growing at a CAGR of 5.91% during the assessment period
Access full report @ https://www.marketresearchfuture.com/reports/electrotherapy-market-3185
1 note · View note
optimainsights-post · 4 years
Text
Urinary Stones Treatment Devices Market to Grow at 4.4% CAGR to Reach US$1.98 billion by 2026
The Global Urinary Stones Treatment Devices Market was valued at US$1.48 billion in the year 2018 and is expected to reach US$1.98 billion by 2026, at a CAGR of 4.4%.
 Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start crystalizing leading to the formation of stones. Depending on the location of the stone development it may be classified as a kidney stone, bladder stone or ureteral stone. These stones are diagnosed using, abdominal X-ray, CT scan, MRI scan, ultrasound, etc. During the early days, the stones were removed through surgical procedures. But the development of technologies such as lithotripsy, ureteroscopy, nephrolithotomy had reduced the hurdles in treatment and the removal of urinary stones. Also growing popularity of digital flexible ureteroscopes and rising focus on the development of lasers alternative to conventional once are the factors that contribute to the market growth.
Urolithiasis and Nephrolithiasis are the main conditions that contribute to the development of kidney stones in individuals and chiefly contribute to market growth. Besides, the recurrence of kidney stones in the adult population has also risen to 50% in recent decades due to enormous changes in the lifestyle, poor dietary habits, an increase in obesity, less intake of water and many other associated morbidities. Moreover, as recent research suggested, the probability of recurrence of nephrolithiasis in adolescents or children is about 50% within 3 years of the first occurrence. According to the National Kidney Foundation, over half a million people across the globe visit emergency rooms every year. International Federation of Kidney Foundations and the International Society of Nephrology are taking several initiatives to create awareness among the people regarding the equitable and inexpensive access to treatment options, screening, and diagnosis. This is set to drive the Urinary Treatment Devices market during the forecast period.
Tumblr media
Implementation of imaging technologies for scanning urinary stones is expected to drive the growth in the upcoming years. Among diagnoses, the ultrasound segment emphasizes reducing the amount of ionizing radiation delivered to patients during routine imaging. It has also become a mainstay tool in the urologists' armamentarium for the diagnosis and management of nephrolithiasis. New advancements in ultrasound technology had also facilitated its use as a therapeutic and therapy guidance aid. Ultrasound is being used as the first line for the diagnosis of urinary stones for more than 14 years and is set to grow with a healthy CAGR of 5.1% during the forecast period. Other diagnostic techniques such as MRI, intravenous pyelogram, non-contrast CT are said to contribute very little when compared to ultrasound.
 Adoption of an alternative way of treatment such as Chinese herbal medicine, Ayurveda, acupressure was minimal during the yesteryears. However, after the rediscovery of the ancient techniques, the options for treating urinary stones with herbal medicine, acupressure, etc. are being researched more and few options have also become successful in minimizing the urinary stones. This is set to hamper the market growth as WHO had already initiated a global level initiative to study and standardize the usage of medicinal plants including that of the folklore medicine.
 However modern medicine offers an effective way of treatment. Among them, the lithotripsy segment has a huge demand in the market treating urinary stones and also to sidestep the invasive surgical procedures that were used for stone removal. Lithotripsy uses ultrasonic energy or shock waves focused directly on the stone to identify the place which was previously located with fluoroscopy or ultrasound of the stones. The patient is positioned in such a way so that the stones are targeted precisely. By using this lithotripsy, the complications, hospital stays, costs and recovery time are reduced. The treatment using lithotripsy is expected to fuel market growth until 2026.
 Among stone types, the calcium oxalate segment has been reported to propel the urinary stones market till 2018. The formation of calcium oxalate stones is strongly linked to the consumption of foods consisting high amount of oxalate that naturally occurs in plants and animals. This includes beets, black tea, chocolate, nuts, potatoes, and spinach. Also, calcium in the form of supplements for several other bone-related disorders may increase the chances of forming new calcium oxalate stones in the urine. Also, consumption of more leguminous foods such as dried beans, peas, anchovies and drinking of beer may increase the chances of uric acid crystal formation due to the deposition of purines in the kidney.
 North American region highly dominates the urinary stones treatment devices market due to extensive prevalence in the occurrence of urinary stones. The favorable conditions for research and development, increased healthcare expenditure and growing utilization of advanced technology for the treatment aspects are evident in this region. The US market holds a market share of about 65% to 35% whereas the Canadian market share is set to increase by around 2% during the forthcoming years due to more immigration from other countries. Further, government initiatives towards strengthening the healthcare infrastructure are accelerating the growth of the urinary stone treatment devices market in this region. Followed by the North American region is the European region, where Germany alone contributes to more than 27% of the total European market growth due to more occurrence of Urolithiasis among German individuals followed by France, the UK, Italy, and Spain. Besides, the Asia Pacific and the Middle East countries are also expected to contribute to the market growth having potential opportunities falling under the kidney stone belt of the world.
 Some of the key players in the urinary stones treatment devices market are, Becton, Dickinson and Company, Boston Scientific Corporation, EDAP TMS S.A., Olympus Corporation, Coloplast A/S, Siemens Healthineers, Convergent Laser Technologies, Cook Medical Inc, Direx Group, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc, KARL STORZ GmbH & Co. KG, Lumenis Ltd, Medispec LTD, Richard Wolf Medical Instruments Corporation, Allengers Medical Systems Ltd and E.M.S. Electro Medical Systems SA.
 Request for Sample Pages @ https://www.optimainsights.org/sample-request/145-urinary-stones-treatment-devices-market
Key Updates:
FDA Approves Retrophin’s New Formula Thiola EC (tiopronin) for treating Cystine Kidney Stones
Dornier’s new Gemini stone-busting system:  The pulverizer is both a step into the future and a blast from the past
Dornier launches AXIS™ Single-Use Digital Ureteroscope for treating Urinary Stones
Journal Summaries in Internal Medicine: Researchers examined the utility of experimental Thulium fiber laser (TFL) as an alternative to the gold standard Holmium: YAG laser for lithotripsy
The Report Provides Key Insights on
History of the Urinary Stones Treatment Devices Market, 2015 to 2017
Forecast of the Urinary Stones Treatment Devices Market Growth till the year 2026
The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Urinary Stones Treatment Devices Market
Analysis of potential growth segments which will drive the market
Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market
Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics
Urinary Stones Treatment Devices Market Based on Diagnosis (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
·         Abdominal X-Ray
·         Computed Tomography(CT) Scan
·         Intravenous Pyelography (IVP)
·         Ultrasound
·         Abdominal MRI
Urinary Stones Treatment Devices Market Based on Treatment (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
·         Percutaneous Nephrolithotomy (PCNL)
·         Ureteroscopy (URS)
·         Extracorporeal Shock Wave Lithotripsy (ESWL)
Urinary Stones Treatment Devices Market Based on Stone Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
·         Calcium Phosphate
·         Cystine
·         Struvite
·         Uric Acid
·         Calcium Oxalate
Urinary Stones Treatment Devices Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
·         North America
·         Europe
·         APAC
·         LAMEA
Urinary Stones Treatment Devices Market Competitive Analysis (Company Overview, SWOT Matrix, Financial, Product Overview, and Market Strategies)
·         Siemens Healthineers
·         Direx Systems Corp
·         Dornier Medtech Gmbh
·         Elmed Electronics & Medical Industry & Trade Inc
·         Karl Storz Gmbh & Co. KG
·         Lumenis Ltd
·         Medispec Ltd
·         E.M.S. Electro Medical Systems SA
 Download Complete TOC of the Report @ https://www.optimainsights.org/request-toc/145-urinary-stones-treatment-devices-market
 About Us
Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.
 Contact
Optima Insights
Mr. Chucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
https://www.optimainsights.org
0 notes
Text
Global Electrotherapy Market Analysis, Application and Forecast to 2021-2027
Bharat Book Bureau Provides the Trending Market Research Report on “Electrotherapy Market: Information By Treatment Type (Extracorporeal Shock Wave Therapy, Interferential Current Therapy, Magnetic Field Therapy, Ultrasound Therapy, Transcutaneous Electrical Nerve Stimulation Therapy, Micro-Current Therapy, Transcutaneous Spinal Electro Analgesia, Pulsed Short Wave Diathermy, Spinal Cord Stimulation, Percutaneous Electrical Nerve Stimulation), By Device Type (Transcutaneous Electrical Neural Stimulator, Electronic Muscle Stimulator, Interferential Stimulator, High Voltage Pulsed Galvanic Stimulator, Microcurrent Stimulator), By Application (Pain Management, Neuromuscular Dysfunction, Urine & Fecal Incontinence, Acute and Chronic Edema, Tissue Repair, Iontophoresis, Orthopedics, Cardiology), By End Users (Hospitals & Clinics, Rehabilitation Centers, Long-Term Care Centers), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2027”under  Life Sciences Market Research Reports Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.
The Electrotherapy Market is anticipated to record a healthy CAGR of 5.10% during the review period, to surpass USD 1,463.74 million by the end of 2027. The factors expected to propel the global market growth are the growing prevalence of sports injuries, technological advancements and new product launches, and rising healthcare expenditure.
The development of the electrotherapy market is driven by the innovative progressions in electrotherapy frameworks, expanding corpulence, rising number of sports wounds, and expanding medical services consumption are the main considerations driving the development of the worldwide electrotherapy market. Notwithstanding, the absence of mindfulness about the utilization of electrotherapy frameworks in non-industrial nations; accessibility of many substitutes; and immersion in created nations are upsetting the development of this market. Also, aside from public consumption of medical services, a few speculations by makers, financial speculators, and new items in the worldwide intracranial drain finding and therapy market are relied upon to drive the market development.
Market Segmentation The electrotherapy market is classified into treatment type, device type, application, and end-user.
Based on treatment type, the market has been classified into extracorporeal shock wave therapy, interferential current therapy (IC), magnetic field therapy, ultrasound therapy, transcutaneous electrical nerve stimulation (TENS) therapy, micro-current therapy, transcutaneous spinal electro analgesia (TSE), pulsed short wave diathermy (PSWD), spinal cord stimulation (SCS), percutaneous electrical nerve stimulation (PENS), and others. Based on device type, the global electrotherapy market has been classified into transcutaneous electrical neural stimulator (TENS), electronic muscle stimulator (EMS), the interferential stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS), microcurrent stimulator (MC), or microcurrent electrical neuromuscular stimulator (MENS), and others.
In terms of application the market has been categorized into pain management, neuromuscular dysfunction, urine and fecal incontinence, acute and chronic edema, tissue repair, iontophoresis, orthopedics, cardiology, and others. The pain management segment is again segmented into chronic pain, chronic fatigue, migraine headaches, wound healing, diabetic nerve pain, stimulating bone growth, and others.
Based on end-users the electrotherapy market is divided into hospitals & clinics, rehabilitation centers, long-term care centers, and others.
Regional Analysis Geographically, the electrotherapy market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas led the market in 2019 and is probably going to keep on directing during the appraisal time frame because of the set up medical services foundation, developing mindfulness identified with electrotherapy, and the presence of central members in the area.
The European electrotherapy market has been partitioned into Western Europe and Eastern Europe. The Western Europe electrotherapy market has additionally been arranged into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe would follow the Americas as far as worth during the figure time frame because of the expanding geriatric populace, the rising commonness of constant and way of life-related conditions, created medical care infrastructure, and high medical services spending.
Major Players The major players operating in global electrotherapy market are Medtronic plc (Ireland), Alimed, Inc (US), Cogentix Medical, Inc. (US), Jude Medical Inc. (US), Zynex Medical (US), DJO Global, Inc. (US), Livanova Plc (UK), Nervo Corp (US), Neuromextrix Inc. (US), and Boston Scientific Corporation (US)
COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Browse our full report with Table of Content : https://www.bharatbook.com/report/1045910/electrotherapy-market-information-by-treatment-type-extracorporeal-shock-wave-therapy-interferential-current-therapy-magnetic-field-therapy-ultrasound-therapy-transcutaneous-electrical-nerve-stimulation-therapy-micro-current-therapy-transcutaneous-spinal-electro-analgesia-pulsed-short-wave-diathermy-spinal-cord-stimulation-percutaneous-electrical-nerve-stimulation-by-device-type-transcutaneous-electrical-neural-stimulator-electronic-muscle-stimulator-interferential-stimulator-high-voltage-pulsed-galvanic-stimulator-microcurrent-stimulator-by-application-pain-management-neuromuscular-dysfunction-urine-fecal-incontinence-acute-and-chronic-edema-tissue-repair-iontophoresis-orthopedics-cardiology-by-end-users-hospitals-clinics-rehabilitation-centers-long-term-care-centers-and-region-americas-europe-asia-pacific-and-middle-east-africa-forecast-till
About Bharat Book Bureau: Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at: Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: [email protected] Website: www.bharatbook.com
0 notes
Text
Extracorporeal Shock Wave Therapy Devices Market 2021 Industry Outlook, Key Players, Segmentation Analysis, Business Growth and Forecast to 2027
Extracorporeal Shock Wave Therapy Devices  Market Overview:
Extracorporeal shock wave therapy device is an electronic device that generates low-intensity sound waves without delay and interfaces with an individual's affected area via gel medium. Shockwave therapy offers a wide range of applications, including orthopaedics, physiotherapy, urology, sports medicine, veterinary medication treatment, rehabilitation centres, and plastic surgery. It's a non-surgical therapy for treating soft tissue issues, chronic pain, and promoting the body's natural healing system for afflicted bones and tendons.
Extracorporeal Shock Wave Therapy Devices Market Report Scope the latest industry report on the global Extracorporeal Shock Wave Therapy Devices  market assesses the opportunities and current market landscape, offering insights and updates on the corresponding segments for the forecasted period of 2021-2027. The report contains a complete analysis of major market dynamics as well as detailed information on the global Extracorporeal Shock Wave Therapy Devices   market's structure. This market research report provides unique insights into how the global Extracorporeal Shock Wave Therapy Devices   market is expected to grow from 2021 to 2027.
The primary goal of the Extracorporeal Shock Wave Therapy Devices   market research is to provide detailed information on market opportunities that are assisting in the transformation of global Extracorporeal Shock Wave Therapy Devices   enterprise. Report  provide projected growth rates along with the compound annual growth rate (CAGR) for forecasted period to enable readers to better understand the monitoring and assessment of the global Extracorporeal Shock Wave Therapy Devices   market, as well as to discover lucrative opportunities in the market.
Request for free sample: https://www.maximizemarketresearch.com/request-sample/55908
Extracorporeal Shock Wave Therapy Devices  Market Scope:
Maximize Market Research, report provide overall market insights for manufacturers, suppliers, distributors, and investors in the global Extracorporeal Shock Wave Therapy Devices  market. The information and data offered in the report may be used by all stakeholders in the global Extracorporeal Shock Wave Therapy Devices  market, as well as industry professionals, researchers, journalists, and business researchers.
Maximize Market Research, report provides a unique research approach to conduct detailed research on the global Extracorporeal Shock Wave Therapy Devices   market and make conclusions on the market's future growth factors. Primary and secondary research methodologies are combined in the research approach to assure the authenticity and validity of the conclusions in this report.
The report discusses the Extracorporeal Shock Wave Therapy Devices  market's drivers, restraints, opportunities, and challenges. The research helps to identify the market growth drivers and determining how to utilize these factors as strengths. Restraints can assist readers in identifying traits that are restricting the Extracorporeal Shock Wave Therapy Devices  market, as well as reducing them before they become an issue.  This will assist readers in comprehending the aspects that will influence your ability to capitalise on possibilities.
Extracorporeal Shock Wave Therapy Devices  Market Segmentation:
Global Extracorporeal Shock Wave Therapy Devices Market, By Product Type
• Table-top/Portable ESWT Device • Hand-push Type ESWT Device Global Extracorporeal Shock Wave Therapy Devices Market, By Application
• Orthopaedic • Cardiology • Erectile Dysfunction • Urology • Others
The orthopaedic and urology categories dominated the global market, and this trend is predicted to continue through 2027, with a little increase in market share. Increased adoption of pain-free treatment procedures among the younger population, value added features provided by shock wave therapy devices, and promotion of cellular proliferation, tissue regeneration, and angiogenesis have all contributed to the segments' projected share.
Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-extracorporeal-shock-wave-therapy-devices-market/55908/
Extracorporeal Shock Wave Therapy Devices  Market Key Players:
• Chattanooga • BTL • Storz Medical • EMS Electro Medical Systems • MTS Medical • Zimmer MedizinSysteme • Gymna • Likamed GmbH • Inceler Medikal • HANIL-TM • HnT Medical • Urontech • Wikkon • Longest • Xiangyu Medical • Shengchang Medical • Bio-Med Inc.
The competitive landscape shows the market share of major key competitors, as well as their key development plans and current financial performance over the previous five years. This information is anticipated to help businesses understand their competitors on a global level. Furthermore, the reports feature company profiles, product offers, critical financial data, country-level research, and a synthesis of demand and supply variables that influence market growth.
Extracorporeal Shock Wave Therapy Devices  Market Regional Analysis:
Geographically, Extracorporeal Shock Wave Therapy Devices  market report is segmented into several key regions are as follows,
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (the United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.) Furthermore, the study covers market size, growth rate, import and export, as well as country-level analysis, integrating the demand and supply forces of the Extracorporeal Shock Wave Therapy Devices  market in these countries, which are impacting market growth.
COVID-19 Impact Analysis on Extracorporeal Shock Wave Therapy Devices  Market:
COVID-19's global influence on the Extracorporeal Shock Wave Therapy Devices  market was examined in this research. During this crisis, the report examines the Extracorporeal Shock Wave Therapy Devices  market's alternatives, demanding conditions, and difficult possibilities in detail. In terms of funding and market expansion, the paper briefly examines the COVID-19's merits and limitations. The study also contains a set of concepts that should aid readers in developing and planning company strategies.
The report considers consultations to overcome past disruptions and foresees potential ones in order to improve preparation. Businesses can use the frameworks to design their strategic alignments in order to recover from such disruptive trends. Maximize Market Research analysts can also assist readers in breaking down a complex circumstance and bringing resiliency to a situation that is uncertain.
About Us:
Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.
Contact Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway,
Narhe, Pune, Maharashtra 411041, India.
Phone No.: +91 20 6630 3320
Website: www.maximizemarketresearch.com
0 notes
techsciresearch · 3 years
Text
Why are Major Conglomerates Suddenly Splitting Up into New Corporate Entities? | TechSci Research
There has been a crazy new trend of ginormous global companies dismantling into multiple entities as diversification isn’t a rage in the corporate world. Companies like Johnson & Johnson, GE, Pfizer, Merck, GlaxoSmithKline have recently announced their corporate divorces, but the splits are not confined to the healthcare sector. Many tech giants, global retail brands, telecom companies have spun off large divisions so that they can invest their time and focus on the most profitable lines of their business.
Tumblr media
The corporate entities split will make each business nimbler in adapting to their respective markets, enable better allocation of capital, and allow better management to make better strategic decisions. Some companies may choose to spin off divisions to provide them greater autonomy and forge better business relationships, which are otherwise made by the colossal conglomerate.
GE Split Marks the End of Conglomerate Era
The largest company by market capitalization, General Electric (GE), is splitting itself into three public units, one for aviation, one for healthcare, and another for building energy products. The industrial powerhouse that once hedged risks by diversifying profit centers is now splitting its entities. The aim is to enable greater focus, tailor capital allocation, and allow strategic flexibility to drive long-term brand growth while creating higher value for customers, investors, and employees.
GE’s breakup of entities has become emblematic of the waning attraction of conglomerate business structure that defined much of the 20th century corporate America. GE healthcare branch would provide more focus on precision health while GE Renewable Energy would lead the energy transition from fossil fuels to clean energy, and GE Aviation would “shape the future of flights.” The independent business will appeal to a deeper investor base due to its unique position. Also, the transformation could help GE realize the full potential of each company.
Johnson & Johnson to Segregate Consumer Products and Pharmaceutical Businesses
Healthcare conglomerate Johnson & Johnson has planned to create two publicly traded companies, splitting its consumer products business from its pharmaceutical and medical device operations. The separation underscores the enhanced focus of J&J on key areas with unmet medical needs and leverage innovation to expand the standard of care and portfolio of life-saving therapies.
J&J split is giving consumer brands such as Tylenol, Neutrogena, Band-Aid, Aveeno, and Listerine much-needed freedom to accommodate changing consumer preferences and economic trends. J&J identified a shift in how people connect to consumer products since the pandemic, often dictated by celebrity influence. The billion-dollar consumer units have untapped potential with highly attractive markets for self-care and wellness.
Toshiba Breaks Up After a Wave of Scandals
Japanese tech giant Toshiba has confirmed plans to take down its “comprehensive electronics manufacturer” shop sign and split the company into three separate businesses, focused on infrastructure and nuclear power generation, and semiconductor chip and memory device. The decision to break a significant entity established in 1875 comes after a series of scandals that shocked the world and tarnished Toshiba’s public image.
The split will clarify corporate entities value and accelerate actions in management-related matters focusing on specialized business areas. Dismantling conglomerates is not a common business strategy, and it remains to be seen whether it will be successful enough to please activist investors.
The motivations that compel gigantic corporations to split can vary significantly. Here are some of the main reasons why gigantic corporations decide to break up.
Enhanced Management
Skills, performance metrics, clients, and management logic are different for every enterprise. While executives are well-suited to one line of business, they might not have the expertise to oversee other companies. For instance, a specific unit may require more attention from the top management to lead to better profit margins and increased revenue.
But, shifting focus on one entity might affect other businesses, which would again affect the overall performance of the conglomerate. The diversification of units under single management might not yield the desired results. Hence, spinoffs become a suitable alternative so that every business can grow to its full potential. By spinning off one or more divisions, management can eventually surpass stock value from what it could have otherwise received from a consolidated unit.
Giant food retail chain Mondelez International was formed as a spinoff from Kraft Foods Group in 2012 to focus on the growing global international snacks and confectionary segment. Today, Mondelez International has become a multi-billion-dollar business with product lines including brands like Cadbury, Oreo, Ritz, Trident, Wheat Thins, etc.
Hewlett Packard Enterprise (HPE) separated from Hewlett Packard for increased focus on IT, cloud, and software products. In fiscal year 2020, HPE reported USD27 billion in revenue while the other unit of HP enhanced focus on building personal computers and printer business.
Attract New Investors
Investors evaluate growing and mature businesses differently. When an organization is split into individual units, the investors in the parent company automatically become investors in the subsidiary unit through a tax-free distribution of new shares. In contrast, the new ones can purchase shares of one or both companies. Historically, spinoffs have been good for investors as both the parent company and subsidiary can outperform the market.
Investors that can comprehend the unpredictability of the initial days and weeks experience much more significant gains. Investors wishing to take advantage of the spinoff must choose wisely between the parent company, subsidiary, or both. Aggressive investors usually invest in subsidiaries as the smaller company has more growth potential than a more established parent company.
For instance, leading oil services company, TechnipFMC is anticipated to complete the spinoff of Technip Energies, which would lead to the separation of company’s core oil services business and its engineering and construction business. So, those who have invested in TechnipFMC will receive a distribution of 50.1%, while the parent company will retain the remaining shares.
Accurate Predictions
Separating organizations into entities can result in higher quality research by the analysts covering those parent companies. According to a recent study, analyst forecast accuracy increases between 30-50% following a spinoff, which helps make better strategic decisions. Besides, when a corporation narrows down its array of businesses, it may attract coverage from security analysts who can provide better forecasts, ultimately benefiting the organization.
Unlocking Shareholder Value
The most significant driving factor for a corporate entities split off is the idea that the parent company is undervalued, either because of management, strategic, or other issues. Corporate’s spinoff one or more business units to increase the valuation of their remaining business. According to a study, the parent companies can see a 14% increase in their share value after a spinoff, while the spun-off companies can see a 22% increase in their share prices.
Besides, the stock split sends a signal to the shareholders that the company’s share price has been increasing, so people invest in those shares, which lifts demand and prices. A company can reduce its share prices through stock splits to make the shares accessible to investors without undermining its value.
According to FactSet Research Systems, spinoff activities of corporates in the past decade have been high in the US, reaching a valuation of USD654 billion in new companies. The wave in the capital markets pushing the companies to be smaller units has resulted in some fresh thinking of corporate entities restructuring.
The frequent spinoffs would help dissipate an incredible amount of inertia against divestitures, offering unique examples of why the value of keeping businesses together can be less profiting than the value of breaking up companies. However, more fundamental recognition about the restructuring of companies is taking place, pushing companies to focus more on shareholder value creation with new corporate entities.
Way Ahead
The new entities formed after breakup from conglomerate will have more ability to allocate capital as per their priorities and become independent of embracing new opportunities without any encumbrance from the parent company. Besides, more focused companies perform better at mergers and acquisitions as compared to a more diversified company.
Get more info visit : https://www.techsciresearch.com
0 notes
Text
Why are Major Conglomerates Suddenly Splitting Up into New Corporate Entities? | TechSci Research
There has been a crazy new trend of ginormous global companies dismantling into multiple entities as diversification isn’t a rage in the corporate world. Companies like Johnson & Johnson, GE, Pfizer, Merck, GlaxoSmithKline have recently announced their corporate divorces, but the splits are not confined to the healthcare sector. Many tech giants, global retail brands, telecom companies have spun off large divisions so that they can invest their time and focus on the most profitable lines of their business.
Tumblr media
The corporate entities split will make each business nimbler in adapting to their respective markets, enable better allocation of capital, and allow better management to make better strategic decisions. Some companies may choose to spin off divisions to provide them greater autonomy and forge better business relationships, which are otherwise made by the colossal conglomerate.
GE Split Marks the End of Conglomerate Era
The largest company by market capitalization, General Electric (GE), is splitting itself into three public units, one for aviation, one for healthcare, and another for building energy products. The industrial powerhouse that once hedged risks by diversifying profit centers is now splitting its entities. The aim is to enable greater focus, tailor capital allocation, and allow strategic flexibility to drive long-term brand growth while creating higher value for customers, investors, and employees.
GE’s breakup of entities has become emblematic of the waning attraction of conglomerate business structure that defined much of the 20th century corporate America. GE healthcare branch would provide more focus on precision health while GE Renewable Energy would lead the energy transition from fossil fuels to clean energy, and GE Aviation would “shape the future of flights.” The independent business will appeal to a deeper investor base due to its unique position. Also, the transformation could help GE realize the full potential of each company.
Johnson & Johnson to Segregate Consumer Products and Pharmaceutical Businesses
Healthcare conglomerate Johnson & Johnson has planned to create two publicly traded companies, splitting its consumer products business from its pharmaceutical and medical device operations. The separation underscores the enhanced focus of J&J on key areas with unmet medical needs and leverage innovation to expand the standard of care and portfolio of life-saving therapies.
J&J split is giving consumer brands such as Tylenol, Neutrogena, Band-Aid, Aveeno, and Listerine much-needed freedom to accommodate changing consumer preferences and economic trends. J&J identified a shift in how people connect to consumer products since the pandemic, often dictated by celebrity influence. The billion-dollar consumer units have untapped potential with highly attractive markets for self-care and wellness.
Toshiba Breaks Up After a Wave of Scandals
Japanese tech giant Toshiba has confirmed plans to take down its “comprehensive electronics manufacturer” shop sign and split the company into three separate businesses, focused on infrastructure and nuclear power generation, and semiconductor chip and memory device. The decision to break a significant entity established in 1875 comes after a series of scandals that shocked the world and tarnished Toshiba’s public image.
The split will clarify corporate entities value and accelerate actions in management-related matters focusing on specialized business areas. Dismantling conglomerates is not a common business strategy, and it remains to be seen whether it will be successful enough to please activist investors.
The motivations that compel gigantic corporations to split can vary significantly. Here are some of the main reasons why gigantic corporations decide to break up.
Enhanced Management
Skills, performance metrics, clients, and management logic are different for every enterprise. While executives are well-suited to one line of business, they might not have the expertise to oversee other companies. For instance, a specific unit may require more attention from the top management to lead to better profit margins and increased revenue.
But, shifting focus on one entity might affect other businesses, which would again affect the overall performance of the conglomerate. The diversification of units under single management might not yield the desired results. Hence, spinoffs become a suitable alternative so that every business can grow to its full potential. By spinning off one or more divisions, management can eventually surpass stock value from what it could have otherwise received from a consolidated unit.
Giant food retail chain Mondelez International was formed as a spinoff from Kraft Foods Group in 2012 to focus on the growing global international snacks and confectionary segment. Today, Mondelez International has become a multi-billion-dollar business with product lines including brands like Cadbury, Oreo, Ritz, Trident, Wheat Thins, etc.
Hewlett Packard Enterprise (HPE) separated from Hewlett Packard for increased focus on IT, cloud, and software products. In fiscal year 2020, HPE reported USD27 billion in revenue while the other unit of HP enhanced focus on building personal computers and printer business.
Attract New Investors
Investors evaluate growing and mature businesses differently. When an organization is split into individual units, the investors in the parent company automatically become investors in the subsidiary unit through a tax-free distribution of new shares. In contrast, the new ones can purchase shares of one or both companies. Historically, spinoffs have been good for investors as both the parent company and subsidiary can outperform the market.
Investors that can comprehend the unpredictability of the initial days and weeks experience much more significant gains. Investors wishing to take advantage of the spinoff must choose wisely between the parent company, subsidiary, or both. Aggressive investors usually invest in subsidiaries as the smaller company has more growth potential than a more established parent company.
For instance, leading oil services company, TechnipFMC is anticipated to complete the spinoff of Technip Energies, which would lead to the separation of company’s core oil services business and its engineering and construction business. So, those who have invested in TechnipFMC will receive a distribution of 50.1%, while the parent company will retain the remaining shares.
Accurate Predictions
Separating organizations into entities can result in higher quality research by the analysts covering those parent companies. According to a recent study, analyst forecast accuracy increases between 30-50% following a spinoff, which helps make better strategic decisions. Besides, when a corporation narrows down its array of businesses, it may attract coverage from security analysts who can provide better forecasts, ultimately benefiting the organization.
Unlocking Shareholder Value
The most significant driving factor for a corporate entities split off is the idea that the parent company is undervalued, either because of management, strategic, or other issues. Corporate’s spinoff one or more business units to increase the valuation of their remaining business. According to a study, the parent companies can see a 14% increase in their share value after a spinoff, while the spun-off companies can see a 22% increase in their share prices.
Besides, the stock split sends a signal to the shareholders that the company’s share price has been increasing, so people invest in those shares, which lifts demand and prices. A company can reduce its share prices through stock splits to make the shares accessible to investors without undermining its value.
According to FactSet Research Systems, spinoff activities of corporates in the past decade have been high in the US, reaching a valuation of USD654 billion in new companies. The wave in the capital markets pushing the companies to be smaller units has resulted in some fresh thinking of corporate entities restructuring.
The frequent spinoffs would help dissipate an incredible amount of inertia against divestitures, offering unique examples of why the value of keeping businesses together can be less profiting than the value of breaking up companies. However, more fundamental recognition about the restructuring of companies is taking place, pushing companies to focus more on shareholder value creation with new corporate entities.
Way Ahead
The new entities formed after breakup from conglomerate will have more ability to allocate capital as per their priorities and become independent of embracing new opportunities without any encumbrance from the parent company. Besides, more focused companies perform better at mergers and acquisitions as compared to a more diversified company.
Get more info visit : https://www.techsciresearch.com/
0 notes
wiseguyreport1222 · 3 years
Link
0 notes
healthcare-market · 3 years
Text
Shock Wave Therapy Device Market Development and Future Demand Analysis Report
Transparency Market Research (TMR) has published a new report titled “Shock Wave Therapy Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report the global shock wave therapy device market was valued at US$ 91.6 Mn in 2016 and is projected to expand at a CAGR of 5.0% from 2017 to 2025. The report suggests that increase in number of bone injuries and rise in demand for chair time optimization is projected to boost the shock wave therapy device market during the forecast period (2017 to 2025). North America and Europe are projected to dominate the global market owing to increase in adoption of shock wave therapy device for treatment by orthopedic doctors and patients. The market in Asia Pacific is projected to expand at exponential CAGR during the forecast period. Growth of market in Asia Pacific is attributed to large number of private clinics and hospitals, rise in the number of geriatric population requiring physiotherapy services after bone surgery, and increase in adoption of sports activities among the youth. The market for shock wave therapy device in Latin America is likely to expand at moderate growth rate during the forecast period.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13457
Value Added Features in Shock Wave Therapy Device to Fuel Global Market Expansion
The global shock wave therapy device market is projected to be driven by value added features offered by various shock wave therapy device companies to streamline the day-to-day work flow and increase revenue of practices. The shock wave therapy device provides a wide range of features and benefits from patient pain healing remedies to treatment procedures at varied frequencies. These features help physicians and nurse to streamline physiotherapy activities required for the patients to maintain their daily routine efficiently and effectively. Key players offering shock wave therapy devices are coming up with value added features such as effective probes, sensors, ultrasound devices, laser connectivity, effective modality features, and imaging modules, thereby reducing the overall operating cost and improving the effectiveness and efficiency of physiotherapy. These companies are focusing on developing combined shock wave therapy facilities in their system to effectively integrate therapy or treatment procedure along with imaging tools such as cameras, digital radio-graphs, high sensors, and patient education & awareness programs. These value added features save operational time of physicians and help improve pain management performance.
Radial or Ballistic Shock Wave Generation is Projected to be a Highly Lucrative Deployment Mode
Focused shock wave generation based technology is commonly used in the pain management therapy. This technology is associated with electromagnetic, electrohydraulic, and piezoelectric methodology. Price of this technology is based on perpetual license model. The radial or ballistic shock wave generation technology enables the usage of shock wave therapy device in low frequency clinical applications. This allows healing of extreme pain in musculoskeletal structures and assures 90% recovery. These attributes are likely to propel the segment during forecast period. Radial or ballistic shock wave generation based technology addresses specific challenges faced during the treatment procedure due to its low frequency shock wave therapy. The radial or ballistic shock wave generation technology provides pain relief, increase in range of motion and muscular strength in patients who have undergone bone injury.
Orthopedic and Urology Application of Shock Wave Therapy Device Leads the Market
The report offers detailed segmentation about applications of shock wave therapy device into orthopedic, cardiology, erectile dysfunction and urology. The orthopedic and urology segment is expected to account for a leading share of the market during the forecast period (2017-2025). High share of the orthopedic and urology segments are attributed to rise in orthopedic surgeries, prevalence of kidney stones among global population, and increase in demand for lithotripsy by physicians and patients contribute to the high market share of the orthopedic and urology segments. Furthermore, availability of various reimbursement and Medicare benefits for patients for the treatment of diseases is projected to propel the orthopedic & urology segments.
Request for Analysis of COVID19 Impact on Shock Wave Therapy Device Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=13457
Hospitals Segment to Dominate the Market During the Forecast Period
The hospitals segment accounted for a leading share of the global shock wave therapy device market. It is estimated to gain market share by the end of 2025. The segment is expected to expand at a CAGR of more than 5% during the forecast period. Expansion of the specialized pain management service, increase in number of orthopedic patient footfall in hospitals, and adoption of digital platforms for marketing pain management practices has contributed to the dominant share of the segment. Increase in number of multinational hospital chains and high digitization budgets are likely to drive the hospitals segment during the forecast period. High prevalence and incidence rates of bone injuries and kidney stones and increase in number of cases of erectile dysfunction across the global has increased patient flow to clinics. These factors are expected to fuel the clinic segment between 2017 and 2025.
Asia Pacific to Create Business Development Opportunities
North America and Europe accounted for a major share of the global shock wave therapy device market in 2016 and are likely to gain their share by 2025. High adoption of digital platforms for pain management, rise in health care budgets, and government initiative to promote minimally invasive surgery techniques have contributed to the dominant market share of these regions. Asia Pacific is projected to be the most lucrative market, with highest attractiveness index. The market in the Asia Pacific region is projected to expand at a CAGR of over 6% during the forecast period. Expansion of the market in the region is due to large number of clinics in emerging countries such as India and China, well established health care facilities and high adoption of digital health care technology in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. Market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.
Buy now Shock Wave Therapy Device Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=13457&ltype=S
Key trend of research and development among the leading Players to Increase Geographic Presence has been observed in last few years.
The report also provides profiles of leading players operating in the global shock wave therapy device market. EMS Electro Medical Systems S.A., BTL Corporate, Dornier MedTech GmbH, and Zimmer MedizinSysteme GmbH are some leading players operating in the global shock wave therapy device market. These companies are engaged in increasing their geographic presence through strategic acquisition and collaboration with other leading players. In October 2017, Dynatronics Corporation partnered with Zimmer MedizinSysteme GmbH (Zimmer) for exclusive distribution of select therapy equipment in the U.S. Other prominent players operating in the global shock wave therapy device include Siemens AG, Boston Scientific Corporation, ?NCELER MEDICAL LTD, and Guangzhou Longest Science & Technology Co.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html
https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/
0 notes
pavanghage · 3 years
Text
Shockwave Therapy Device Market Growth By Top Companies with Forecast 2027
"
Shockwave Therapy Device Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.
Sample Copy of This Report:https://axelreports.com/request-sample/54925
A 360 degree outline of the competitive scenario of the Global Shockwave Therapy Device Market is presented by Axel Reports Market Insights. It has a massive data allied to the recent product and technological developments in the markets.
It has a wide-ranging analysis of the impact of these advancements on the market’s future growth, wide-ranging analysis of these extensions on the market’s future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.
Reasons for buying this report:
It offers an analysis of changing competitive scenario.
For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
It offers seven-year assessment of Global Shockwave Therapy Device
It helps in understanding the major key product segments.
Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
It offers regional analysis of Global Shockwave Therapy Device Market along with business profiles of several stakeholders.
It offers massive data about trending factors that will influence the progress of the Global Shockwave Therapy Device
Get ToC for the overview of the premium report @ https://axelreports.com/industry-analysis/2021-2027-global-and-regional-shockwave-/54925
By Market Players: Boston Scientific Corporation Edaptms TMS Lumenis Ltd. C.R. Bard Inc. Cook Group Inc. Dornier MedTech GmbH Karl Storz Olympus Corporation Medtrue Enterprise Co. Ltd. Siemens AG By Type Mobile Shock Wave Therapy Devices Fixed Shock Wave Therapy Devices By Application Hospitals Physiotherapy Centers Clinics Radiology Labs Others
A detailed outline of the Global Shockwave Therapy Device Market includes a comprehensive analysis of different verticals of businesses. North America, Latin America, Asia-Pacific, Africa, and Europe have been considered for the studies on the basis of several terminologies.
This is anticipated to drive the Global Shockwave Therapy Device Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Shockwave Therapy Device Market are currently adopting new technological trends in the market.
Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Shockwave Therapy Device Market. The feasibility of the new report is also measured in this research report.
Make an Enquiry for purchasing this Report :https://axelreports.com/enquiry-before-buying/54925
Table of Contents:
Global Shockwave Therapy Device Market Overview
Economic Impact on Industry
Market Competition by Manufacturers
Production, Revenue (Value) by Region
Production, Revenue (Value), Price Trend by Type
Market Analysis by Application
Cost Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders
Market Effect Factors Analysis
Global Shockwave Therapy Device Market Forecast
ABOUT US:
Axel Reports has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.
Contact: Axel Reports Akansha G (Knowledge Partner) Office No- B 201 Pune, Maharashtra 411060 Phone: US +18488639402 Email: [email protected]/ Web: https://axelreports.com/
"
0 notes
blueweave · 3 years
Text
Global Autoinjectors Market Gaining Momentum—Projected to Reach Worth USD 120.2 Billion in 2027
A study recently conducted by the strategic consulting and market research firm, BlueWeave Consulting revealed that the global autoinjectors market was worth USD 44.3 billion in 2020 and is further projected to reach USD 120.2 billion by 2027, at a CAGR of 15.4% during the forecast period (2021-2027). Autoinjectors have a number of advantages, including reducing the risk of needle-related phobia disorder, decreasing the risk of needle-stick injuries, maintaining dose quality accuracy, and increasing efficacy. The global demand for autoinjectors is growing as a result of these advantages. Furthermore, the growing number of targeted treatments, technical advances, and regulatory approvals all contribute to the market's development.
Tumblr media
Rising Incidence of Anaphylaxis
Anaphylaxis is an allergic reaction to venom, food, or medicine that can be fatal. The majority of cases are caused by bee stings or consuming foods that cause allergies, such as peanuts or tree nuts. The symptoms of anaphylaxis, also known as anaphylactic shock, include rash, low pulse, and shock. According to a NICE analysis, anaphylaxis-like reactions occur in 1 in 1,000 individuals. Unless a safe combination of drugs can be found, anaphylaxis occurs in 1 in 10,000–20,000 anesthetics during general anesthesia. The administration of epinephrine is the first step in the treatment of anaphylaxis. Pre-filled autoinjectors are used to treat life-threatening allergic emergencies, such as anaphylaxis, in people who are at risk or who have had serious allergic reactions in the past. The rising incidence of anaphylaxis drives the market growth for the global autoinjectors market.
Increasing Number of Regulatory Approvals
Any registrations, licenses, authorizations, permits, or approvals granted by any governing body, as well as applications or submissions relevant to any of the above, are referred to as regulatory approvals. Before a pharmaceutical or biotechnology company may launch a new product, it must first obtain approval from regulatory bodies such as the World Health Organization (WHO), the Food and Drug Administration (FDA), and various country-based medical regulatory bodies.
Over the last few years, the successful integration of emerging technology with medical device expertise has resulted in the introduction of new medical devices that have been approved by regulatory bodies. For instance, on 12 April, 2021, The Therapeutic Goods Administration (TGA) has approved new autoinjectors for the emergency treatment of anaphylaxis caused by insect stings, food or other allergens, with Allergy Concepts’ Anapen 500, Anapen 300 and Anapen 150 Junior adrenaline added to the Australian Register of Therapeutic Goods. With the approval, anaphylaxis sufferers in Australia who weigh 110 pounds or more will now have access to a 500 mcg adrenaline autoinjector dose.
Rheumatoid Arthritis Segment Held the largest Share in Autoinjectors Market in 2020
The global autoinjectors market, by therapy, is segmented into rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, multiple sclerosis, and other therapies. Rheumatoid accounted for the largest share in the market in 2020. The growth can be attributed to the rising prevalence of rheumatoid arthritis among people in the last few years. According to the Centers for Disease Control and Prevention, by 2040, an estimated 78 million (26%) of US adults aged 18 and up will have doctor-diagnosed arthritis. The impact of arthritis on individuals is significant. Around 23.7 million of the 54.4 million adults with doctor-diagnosed arthritis have limitations in their daily activities as a result of their arthritis. The rising prevalence of rheumatoid arthritis and patient use of autoinjectors has boosted the market's growth.
Impact of COVID-19
The rapid spread of COVID-19 has prompted governments around the world to declare a national lockdown. As soon as the government instituted a lockdown, development in a variety of sectors came to a halt. COVID-19 is now in its second wave, with countries like India and Brazil among the worst-hit countries. Though COVID-19 has negatively impacted many industries, it caused the global autoinjectors market to expand faster. The business is growing as a result of the protocols put in place by various governments and the nationwide lockdown. Since patients are unable to attend hospitals due to the increasing spread of the coronavirus infection, autoinjectors have found a lucrative business opportunity. Patients with chronic illnesses and allergies prefer autoinjectors that can be used at home in this case. This often protects high-risk groups from being exposed to viruses during hospital visits.
Global Autoinjectors Market: Regional Insights
Geographically, the global autoinjectors market is categorized into North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America. The Asia-Pacific leads the global autoinjectors market and is projected to lead the overall market during the forecast period as well. The demand in this region is increasing due to the growing presence of geriatric population in the region, which has resulted in an increase in the prevalence of diseases such as diabetes and cancer. However, the market is driven by improving healthcare infrastructure, which is accompanied by growing technological developments in this area.
Competitive Landscape
The high growth potential of the autoinjectors market has attracted a slew of new entrants, generating a profitable opportunity. The arrival of new entrants has boosted competition among long-standing service providers. Moreover, companies are currently working with various R&D organizations and research institutes to create advanced and biodegradable autoinjectors.
Some of the key players in the market are AbbVie Inc., Mylan, Eli Lilly and Company, Ypsomed, Amgen, Becton, Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson, Teva Pharmaceutical, Antares Pharma, Merck KGaA, and other prominent players. In order to improve their production capability, product portfolio, and provide competitive differentiation, companies are increasingly participating in acquisitions, alliances, and mergers, besides launching innovative products. For instance, on 21 July 2020, Antares Pharma, Inc. announced the introduction of its multidose pen platform in Europe for the first time. These pens are cost-effective and also easy to use. Market players are also aiming to achieve competitive market share by selling new goods.
Don’t miss the business opportunity of the global autoinjectors market. Consult our analysts to gain crucial insights and facilitate your business growth.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global autoinjectors market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the ­­­autoinjectors market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
0 notes
sapanas · 3 years
Text
Electrotherapy Market 2021 Global Analysis With Focus On Opportunities, Comprehensive Analysis | Aggrandizes Phenomenally By 2027 With A Whooping CAGR
Electrotherapy Market– Overview
The rise in the acceptance of physiotherapy for treating various ailments has also bolstered the demand for electrotherapy globally. Market reports linked to the medical device industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios. The market is anticipated to expand with a 4.2% CAGR while achieving revenues totaling US$ 1119.1 million by the end of the forecast period.
The upsurge in the number of cases related to soft tissue injuries and muscles impairments are increasing the demand for electrotherapy devices. The electrotherapy market is expected to gain substantial traction due to the increased inclination of customers towards drug-free methods of treatment. Furthermore, the awareness of the benefits of electrotherapy is anticipated to provide more avenues for growth in the upcoming forecast period.
Access Report @ https://www.marketresearchfuture.com/reports/electrotherapy-market-3185
Electrotherapy Market Segmental Analysis
The electrotherapy market has been segmented on the basis of type, devices, application, and region. On the basis of type, the market is segmented into Interferential, Extracorporeal Shock Wave Therapy, Magnetic Field Therapy (Pulsed Electro-Magnetic Field Energy, Constant Energy Magnets), Transcutaneous Electrical Nerve Stimulation (TENS) Therapy (Intense TENS, Conventional TENS, Acupuncture-like TENS (AL-TENS)), Ultrasound Therapy, and others. The segmentation on the basis of devices comprises of Electronic Muscle Stimulator (EMS), High Voltage Pulsed Galvanic Stimulator (HVPGS), Transcutaneous Electrical Neural Stimulator (TENS), Interferential Stimulator (IF), Microcurrent Stimulator (MC) or Microcurrent Electrical Neuromuscular Stimulator (MENS), among others. The segmentation of the electrotherapy market on application basis comprises of orthopedics, cardiology, urology, pain management (chronic fatigue, chronic pain, migraine headaches, diabetic nerve pain, wound healing, stimulating bone growth), Chronic and Acute Edema among others. The regions covered in the market are Europe, North America, Asia Pacific, Africa, and the Middle East.
Electrotherapy Market Regional Analysis
The regional analysis of the electrotherapy market comprises of regions such as North America, Europe, Asia Pacific, Africa, and the Middle East. The North American region is the major market for electrotherapy. In the North America region, the US controls a major market share while the European market is the next major region in the market. The growth rate is relatively higher in west European countries. Conversely, the Asia Pacific region is a rapidly growing market and is anticipated to control the market by the year 2023. The Middle East and African region are expected to have restrained growth in the market owing to a low-level awareness of the devices and treatment.
Electrotherapy Market Competitive Analysis
The plan formulation process in the market has become significantly easier in which deviations are well accounted for; this approach increases the overall success of these plans in the market. The leadership trends in the market are reinforcing the level of growth that can be achieved in the present market scenario. The alterations seen in terms of strategy execution and creation are altering the development pace of the market. The evolution patterns are revised in tandem to the customer likings to realize the greatest growth, and in the long run, viability. The framework for growth plans also has stimulated the market for potential new entrants. The market contenders are making considerable adjustments to minimize the incidence of competitive disadvantage. The market is also well equipped to meet the challenges and keep up with the dynamic growth trends effectively. The noteworthy competitors in the electrotherapy market are Eme srl (Italy), BTL (Czech Republic), EMS Physio Ltd. (UK), Medtronic (Republic of Ireland), Enraf-Nonius B.V.(Netherlands), Pure Care (US), gbo Medizintechnik AG (Germany), Phoenix Healthcare (UK), Omron Healthcare, Inc. (US), Walgreen Co. (US), STYMCO Technologies, LLC (US) and others
Electrotherapy Industry Updates:
Jan 2018 Omron lately introduced its first wireless at-home drug-free pain management device, Avail, which is an FDA-cleared TENS device designed to provide symptomatic relief and management of acute and chronic pain. Avail is fully wireless and uses two contoured pads that permits users to treat multiple pain sites simultaneously.
1 note · View note